TITLE

Excellence Through Self-Administration

AUTHOR(S)
Marton, Betty A.
PUB. DATE
April 2012
SOURCE
HealthLeaders Magazine;Apr2012, Vol. 15 Issue 4, p54
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the advantage of letting cystic fibrosis (CF) patients administer their own medications. Given example is the case of a 23-year-old CF patient who was able to deliver a healthy and full-term baby girl at Long Island Jewish Medical Center. It notes that self administration allows healthcare providers to reeducate their patients on how to use their medicines.
ACCESSION #
76361608

 

Related Articles

  • Clinical outcome in relation to care in centres specialising in cystic fibrosis: Cross sectional... Mahadeva, Ravi; Webb, Kevin; Westerbeck, Roger C.; Carroll, Nick R.; Dodd, Mary E.; Bilton, Diana; Lomas, David A. // BMJ: British Medical Journal (International Edition);06/13/98, Vol. 316 Issue 7147, p1771 

    Assesses the effects of the management of paediatric and adult cystic fibrosis patients on their clinical outcome, while highlighting a cross sectional study conducted. Reference to the prevalence of cystic fibrosis in Northern Europe; Provisions of cystic fibrosis patients; Complexity of the...

  • Commentary: Management in paediatric and adult cystic fibrosis centres improves clinical... Dodge, J.A. // BMJ: British Medical Journal (International Edition);06/13/98, Vol. 316 Issue 7147, p1775 

    Commentary. Comments on an article which assessed the importance of management on the clinical outcome of patients with cystic fibrosis. Importance of cystic fibrosis centers; Criticism of claims made by the authors of the article; Factors which should be taken when managing the health of...

  • Hot off the breath: 'I've a cost for'dthe 64 million dollar question. Bush, Andrew; Simmonds, Nicholas J. // Thorax;May2012, Vol. 67 Issue 5, p382 

    The author discusses the license of Ivacaftor issued by U.S Food and Drug Administration for cystic fibrosis patients. He states that if these patients receive this medication the budget extend to millions as there will be no profit to cover the costs of this medication. He informs about the...

  • Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Byrne N M; Keavey P M; Perry J D; Gould F K; Spencer D A // Archives of Disease in Childhood;Aug2003, Vol. 88 Issue 8, p715 

    AIM: To examine the effectiveness of delivery of nebulised colistin by the HaloLite nebuliser compared to the Pari LC Plus in patients with cystic fibrosis. METHODS: Randomised crossover trial of 15 patients aged >6 years. Inhalation of one mega unit of colistin in 3 ml diluent, labelled with...

  • Tobramycin.  // Reactions Weekly;10/29/2016, Vol. 1625 Issue 1, p184 

    The article presents a case study of a 30-year-old woman who suffered from cystic fibrosis associated Pseudomonas aeruginosa infection after receiving treatment with tobramycin inhalation.

  • Mycophenolate mofetil/prednisone/tacrolimus.  // Reactions Weekly;10/29/2016, Vol. 1625 Issue 1, p148 

    The article presents a case study of a 38-year-old man, with cystic fibrosis, who developed choroidal abscess secondary to Pseudomonas aeruginosa and endogenous endophthalmitis during treatment with prednisone, tacrolimus and mycophenolate mofetil.

  • Cystic Fibrosis: Recent Successes Present New Challenges. Pilewski, Joseph M.; Taichman, Darren B. // Annals of Internal Medicine;8/19/2014, Vol. 161 Issue 4, following p298 

    The author reflects on success and challenges associated with care and survival of patients with cystic fibrosis (CF). Topics discussed include the role of the Cystic Fibrosis Foundation to establish a patient registry in 1960, the importance of inhaled hypertonic saline to minimize exacerbation...

  • Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis. Jackson, Abaigeal D.; Daly, Leslie; Jackson, Andrew L.; Kelleher, Cecily; Marshall, Bruce C.; Quinton, Hebe B.; Fletcher, Godfrey; Harrington, Mary; Shijun Zhou; McKone, Edward F.; Gallagher, Charles; Foley, Linda; Fitzpatrick, Patricia // Thorax;Aug2011, Vol. 66 Issue 8, p674 

    Background The current lifetable approach to survival estimation is favoured by CF registries. Recognising the limitation of this approach, we examined the utility of a parametric survival model to project birth cohort survival estimates beyond the follow-up period, where short duration of...

  • Ciclosporin Population Pharmacokinetics and Bayesian Estimation in Thoracic Transplant Recipients. Fruit, Dorothée; Rousseau, Annick; Amrein, Catherine; Rollé, Florence; Kamar, Nassim; Sebbag, Laurent; Redonnet, Michel; Epailly, Eric; Marquet, Pierre; Prémaud, Aurélie // Clinical Pharmacokinetics;2013, Vol. 52 Issue 4, p277 

    Background and objectives: Therapeutic drug monitoring of ciclosporin has been recognized as an essential tool in the management of allograft transplant recipients, as it could help improve their outcome. However, there is still no consensus about the optimal method for monitoring ciclosporin...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics